Name (Synonyms) | Correlation | |
---|---|---|
drug1512 | Monitoring Visit - Baseline Wiki | 1.00 |
drug1514 | Monitoring Visit - Week 8 Wiki | 1.00 |
drug1095 | Hydroxychloroquine - Daily Dosing Wiki | 1.00 |
drug1513 | Monitoring Visit - Week 4 Wiki | 1.00 |
drug2690 | Weekly Assessment Wiki | 1.00 |
drug1097 | Hydroxychloroquine - Weekly Dosing Wiki | 0.71 |
drug1853 | Placebo oral tablet Wiki | 0.19 |
drug1822 | Placebo Wiki | 0.06 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
To evaluate the efficacy of a single dose of subcutaneous injections of 180 ug of Peginterferon Lambda-1a, compared with placebo in reducing the duration of viral shedding of SARS-CoV-2 virus in patients with uncomplicated COVID-19 disease.
Description: Time to first of two consecutive negative respiratory secretions obtained by nasopharyngeal and/or oropharyngeal and/or salivary swabs tests for SARS-CoV-2 by qRT-PCR.
Measure: Duration of Viral shedding of SARS-CoV-2 by qRT-PCR Time: 28 days